Background Many obstacles challenge the establishment and expansion of cardiac surgery
in low-and middle-income countries, despite the unmet cardiac surgical needs. One …

Background: There is limited information on long-term outcomes after stroke in sub-Saharan
Africa (SSA). Current estimates of case fatality rate (CFR) in SSA are based on small sample …

Background Effective stroke prevention with oral anticoagulants (OAC) is recommended for
some patients with atrial fibrillation (AF). We aimed to describe OAC use by geographical …

Background Atrial fibrillation/flutter (AF/AFL) significantly impacts countries with varying
income levels. We aimed to present worldwide estimates of its burden from 1990 to 2019 …

Aims Atrial fibrillation/atrial flutter (AF/AFL) remains a significant public health concern on a
global scale, with metabolic risks playing an increasingly prominent role. This study aimed to …

Background Patients with moderate-to-severe mitral stenosis (MS) have bee excluded from
all major randomized controlled trials (RCTs) comparing non-vitamin K antagonist oral …

Informed by the almost unimaginable unmet need for cardiac surgery in the developing
regions of the world, leading surgeons, cardiologists, editors in chief of the major …

The United Nations Sustainable Development Goals for 2030 include a strong focus on
health, wherein it is stated “… to extend life expectancy for all, we must achieve universal …

Atrial fibrillation/atrial flutter (AF/AFL) has progressed to be a public health concern, and high
systolic blood pressure (HSBP) remains the leading risk factor for AF/AFL. This study …

Objective: Oral anticoagulant drugs, such as warfarin, are widely used for preventing and
treating vascular and thromboembolic disease in patients with chronic atrial fibrillation …